,study,anastrozole,anthracycline,anti_HER2,anti_estrogen,aromatase_inhibitor,capecitabine,chemo,cyclophosphamide,docetaxel,doxorubicin,epirubicin,estrogen_receptor_blocker,estrogen_receptor_blocker_and_stops_production,fluorouracil,hormone,letrozole,methotrexate,neoadjuvant_or_adjuvant,no_treatment,paclitaxel,radio,surgery,tamoxifen,taxane,taxaneGeneral,trastuzumab,treatment_protocol_number
0,study_16391_GPL570_all-bmc15,,,,,0:13 / 1:35,,0:30 / 1:18,,,,,0:35 / 1:13,0:13 / 1:35,,,0:13 / 1:35,,adj:30 / mixed:18,,,0:6 / 1:42,1:18 / 2:30,0:35 / 1:13,,,,17 / 16 / 9 / 3 / 2 / 1
1,study_19615_GPL570_all-bmc15,,0:28 / 1:82,0:107 / 1:3,0:51 / 1:59,,0:109 / 1:1,0:28 / 1:82,0:28 / 1:82,0:106 / 1:4,0:29 / 1:81,0:109 / 1:1,0:51 / 1:59,,0:106 / 1:4,0:48 / 1:62,,0:106 / 1:4,,0:102 / 1:8,0:80 / 1:30,,,0:51 / 1:59,0:76 / 1:34,,0:107 / 1:3,23 / 20 / 16 / 15 / 10 / 8 / 4 / 2 / 2 / 2 / 2 / 1 / 1 / 1 / 1 / 1 / 1
2,study_20194_GPL96_all-bmc15,0:260 / 1:1,0:5 / 1:256,0:253 / 1:8,0:259 / 1:2,0:259 / 1:2,0:259 / 1:2,,0:5 / 1:256,,0:71 / 1:190,0:195 / 1:66,,0:259 / 1:2,0:5 / 1:256,0:251 / 1:10,0:260 / 1:1,,,,0:1 / 1:260,,,,0:1 / 1:260,,0:253 / 1:8,156 / 64 / 9 / 7 / 4 / 4 / 3 / 2 / 2 / 2 / 2 / 1 / 1 / 1 / 1 / 1 / 1
3,study_22226_GPL1708_all-bmc15,,,0:115 / 1:13,,,,,,,,,,,,0:115 / 1:13,,,,,,,,,0:4 / 1:124,0:4 / 1:124,0:115 / 1:13,111 / 11 / 4 / 2
4,study_22358_GPL5325_all-bmc15,,,0:95 / 1:27,,,,,,,,,,,,0:95 / 1:27,,,,,,,,,,,0:95 / 1:27,95 / 27
5,study_25065_GPL96_MDACC-bmc15,,,,,,0:37 / 1:34,,,0:37 / 1:34,0:34 / 1:37,0:37 / 1:34,,,,,,,,,0:34 / 1:37,,,,,,,37 / 34
6,study_9893_GPL5049_all-bmc15,,,,,,,,,,,,,,,,,,,,,0:34 / 1:114,,,,,,114 / 34
